Supplementary Information

Hasonló dokumentumok
Supplementary Table 1. Cystometric parameters in sham-operated wild type and Trpv4 -/- rats during saline infusion and

A cell-based screening system for RNA Polymerase I inhibitors

Supporting Information

Suppl. Materials. Polyhydroxyalkanoate (PHA) Granules Have no Phospholipids. Germany

Modular Optimization of Hemicellulose-utilizing Pathway in. Corynebacterium glutamicum for Consolidated Bioprocessing of

Manuscript Title: Identification of a thermostable fungal lytic polysaccharide monooxygenase and

Supporting Information

Supporting Information

The role of aristolochene synthase in diphosphate activation

Supplementary materials to: Whole-mount single molecule FISH method for zebrafish embryo

Supplemental Information. Investigation of Penicillin Binding Protein. (PBP)-like Peptide Cyclase and Hydrolase

University of Bristol - Explore Bristol Research

Nan Wang, Qingming Dong, Jingjing Li, Rohit K. Jangra, Meiyun Fan, Allan R. Brasier, Stanley M. Lemon, Lawrence M. Pfeffer, Kui Li

pjnc-pgluc Codon-optimized Gaussia luciferase (pgluc) Vector backbone: JM83 pjnc-pgluc is resistant to ampicillin and neomycin High or low copy:

Construction of a cube given with its centre and a sideline

Számítógépes Modellezés 11. Differenciálegyenletes modellek. Inga

Expression analysis of PIN genes in root tips and nodules of Lotus japonicus

The beet R locus encodes a new cytochrome P450 required for red. betalain production.

Magas kifolyócsöves mosogató csaptelepek High spout sink mixers

MELLÉKLET / ANNEX. EU MEGFELELŐSÉGI NYILATKOZAT-hoz for EU DECLARATION OF CONFORMITY

Pantone szín táblázat.

Animal welfare, etológia és tartástechnológia

A Lee-Carter módszer magyarországi

vancomycin CFSL cefepime CFPM cefozopran CZOP 4 cephem cefpirome CPR cefoselis Inhibitory Concentration FIC index

Mapping Sequencing Reads to a Reference Genome


TIOLKARBAMÁT TÍPUSÚ NÖVÉNYVÉDŐ SZER HATÓANYAGOK ÉS SZÁRMAZÉKAIK KÉMIAI OXIDÁLHATÓSÁGÁNAK VIZSGÁLATA I

Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by ipsc-derived Oligodendrocytes

Salt-Enabled Visual Detection of DNA

Forensic SNP Genotyping using Nanopore MinION Sequencing

T-helper Type 2 driven Inflammation Defines Major Subphenotypes of Asthma

Supplemental Information. RNase H1-Dependent Antisense Oligonucleotides. Are Robustly Active in Directing RNA Cleavage

Registered Trademark of Hemos Group Austria

Flowering time. Col C24 Cvi C24xCol C24xCvi ColxCvi

Architecture of the Trypanosome RNA Editing Accessory Complex, MRB1

Markerless Escherichia coli rrn Deletion Strains for Genetic Determination of Ribosomal Binding Sites

2.2 TDCi 150LE 4x4 M Ft Ft XLT 2.2 TDCi 150LE 4x4 M Ft Ft

(A F) H&E staining of the duodenum in the indicated genotypes at E16.5 (A, D), E18.5

Melléklet BAZALT ANYAGÚ CSISZOLT KŐESZKÖZÖK KŐZETTANI ÉS GEOKÉMIAI VIZSGÁLATA (BALATONŐSZÖD - TEMETŐI DŰLŐ LELŐHELY)

Minőségjavító kísérlettervezés

Laborvegyszer árlista

Trinucleotide Repeat Diseases: CRISPR Cas9 PacBio no PCR Sequencing MFMER slide-1

DECLARATION OF PERFORMANCE. No. CPR-20-IC-204

A templát reakciók. Template Reactions

Kalman-féle rendszer definíció

Új temékek az UD- GenoMed Kft. kínálatában!

- Supplementary Data

UNIVERSITY OF PANNONIA SYNTHESIS OF FERROCENE-LABELLED STEROID DERIVATIVES VIA HOMOGENEOUS CATALYTIC REACTIONS. THESES OF THE PhD DISSERTATION

PROFESSZIONÁLIS PAPÍRHIGIÉNIA PROFESSIONAL HYGIENE PAPER

Kit Components RC DC Protein Assay Kit EDU


URKI-SYSTEM IPARI FESTÉKRENDSZER

Depending on the load class and nominal size, the inlet invert between mm.

Revenue Stamp Album for Hungary Magyar illetékbélyeg album. Content (tartalom) Documentary Stamps (okmánybélyegek)

4 vana, vanb, vanc1, vanc2

PLATTÍROZOTT ALUMÍNIUM LEMEZEK KÖTÉSI VISZONYAINAK TECHNOLÓGIAI VIZSGÁLATA TECHNOLOGICAL INVESTIGATION OF PLATED ALUMINIUM SHEETS BONDING PROPERTIES

Pályázati felhívás és tájékoztató


Emelt alfa-linolénsav tartalmú tápok hatása a brojler csirke húsminőségére

URBAN PLANNING IN THE AGE OF BIG DATA A NEW EMPIRIUM TELEPÜLÉSTERVEZÁS AZ ADATBŐSÉG KORÁBAN EGY ÚJ EMPÍRIUM

AMINOKARBONILEZÉS ALKALMAZÁSA ÚJ SZTERÁNVÁZAS VEGYÜLETEK SZINTÉZISÉBEN

i1400 Image Processing Guide A-61623_zh-tw

Ivóvíz arzénmentesítése nanoszűréssel

A zsírszövet mellett az agyvelő lipidekben leggazdagabb szervünk. Pontosabban az agy igen gazdag hosszú szénláncú politelítetlen zsírsavakban

NEUTRÍNÓ DETEKTOROK. A SzUPER -KAMIOKANDE példája

SOLiD Technology. library preparation & Sequencing Chemistry (sequencing by ligation!) Imaging and analysis. Application specific sample preparation

A mangán toxicitás mérséklése baktérium tartalmú trágyákkal Reduction of Mn-toxicity effect with the use of bacteria containing fertilizer

PP-por morfológiája a gyártási paraméterek függvényében

Supplementary Figure 1

Tanmenetjavaslat heti 1 óra. Köszönés Bemutatkozás. Ismerkedés. Utasítások. Érdeklődés. Számok Számlálás. Születésnap. Óra, 11, 12.

tccattaattcgacagaccagagttaaataatccttgtatgccattgtgatcacatctacagttcagattttgtatttca

LACOBEL & MATELAC ÚJ SZÍNEK ÚJ TRENDEK

Supplementary: A strategy to optimize the generation of stable chromobody cell lines for

Szívkatéterek hajlékonysága, meghajlítása

Mikroszerkezet Krisztallitonként Tömbi Polikristályos Mintában

Feloldóképesség Mikroszkópos módszerek. DIC mikroszkópia. Fáziskontraszt mikroszkópia. Barkó Szilvia A MIKROSZKÓPIA RÖVID TÖRTÉNETE

Road construction works

Eos H57 aluminum H57 aluminum H57 aluminum H57 aluminum LED 59 W 3880 lm* 230 V. option. LED 59 W 3880 lm* 230 V

Tejsav alapú polimérek

Kulcsszavak: kétfémes katalizátor, pirolízis, szén nanocsövek.

Limitations and challenges of genetic barcode quantification

INFO-CAPITALISM IN CENTRAL EUROPE: THE VISEGRAD STRATEGY. By Pál TAMÁS [Institute of Sociology, HAS, Budapest]

Szakmai önéletrajz. Nyelvvizsga: Angol orvosi szaknyelv középfok (Bizonyítvány száma: D A 794/1997), orosz alapfok.

Biológiai makromolekulák szerkezete

Affinium LED string lp w6300 P10

BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMY FACULTY OF CHEMICAL AND BIOENGENEERING

Mágnesség és elektromos vezetés kétdimenziós

Website review acci.hu

FAGYI-TUDOMÁNY FAKULTATÍV INTEGRÁLT PROJEKT KÖZÉPISKOLÁSOKNAK ICE-CREAM SCIENCE FACULTATIVE SCIENCE PROJECT FOR HIGH SCHOOL STUDENTS

Egyrétegű tömörfalapok ragasztási szilárdságának vizsgálata kisméretű próbatesteken

Page 1 Bulbasaur, Ivysaur, Venusaur Littlemojo (2)

White Paper. Grounding Patch Panels

General information for the participants of the GTG Budapest, 2017 meeting

Tüzelıanyag cellák befektetıi piaca. Magyar Energetikai Társaság Hidrogén Tagozat Dr. Kovács Antal Ferenc Március 3.

FÖLDRAJZ ANGOL NYELVEN

BIOSZORBENSEK ELŐÁLLÍTÁSA MEZŐGAZDASÁGI HULLADÉKOKBÓL SZÁRMAZÓ, MÓDOSÍTOTT CELLULÓZROSTOK FELHASZNÁLÁSÁVAL

Tömegspektrometria. Bevezetés és Ionizációs módszerek

Grafika. Egyváltozós függvény grafikonja

DI-, TETRA- ÉS HEXAPLOID TRITICUM FAJOK GENOMJAINAK ELEMZÉSE ÉS AZOK ÖSSZEHASONLÍTÁSA FLUORESZCENS IN SITU HIBRIDIZÁCIÓVAL

O-gyûrûk és tömítések

Átírás:

Electronic Supplementary Material (ESI) for Catalysis Science & Technology. This journal is The Royal Society of Chemistry 2017 Supplementary Information α-oxidative Decarboxylation of Fatty Acids Catalysed by Cytochrome P450 Peroxygenases Yielding Shorter-Alkyl-Chain Fatty Acids Hiroki Onoda a, Osami Shoji* a, b, Kazuto Suzuki a, Hiroshi Sugimotob, c, Yoshitsugu Shiro d, and Yoshihito Watanabe* e. 1 Department of Chemistry, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-0802, Japan, 2 RIKEN SPring-8 Center, 1-1-1 Kouto, Sayo-cho, Hyogo 679-5148, Japan, and 3 Resarch Center for Materials Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-0802, Japan Address corresponding to: Yoshihito Watanabe, Resarch Center for Materials Science, Nagoya University, Furocho, Chikusa-ku, Nagoya 464-0802, Japan. Email: p47297a@nucc.cc.nagoya-u.ac.jp Osami Shoji, Department of Chemistry, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-0802, Japan. Email: shoji.osami@a.mbox.nagoyau.ac.jp

Material and methods Materials All chemical reagents were purchased from commercial sources and used without further purification. Tridecanoic acid (C 13 ), potassium dihydrogenphosphate, dipotassium phosphate, potassium chloride, 2-(N-morpholino)ethanesulfonic acid (MES), glycerol and dichloromethane were obteined Nacalai Tesque. α-hydroxymyristic acid (C 14 α-oh), hydrogen peroxide and IPTG were obtained from Wako. 99% N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) + 1% trimethylchlorosilane (TCMS) was obtained from TCI. Palmitic acid (C 16 ), myristic acid (C 14 ), β-hydroxymyristic acid (C 14 β-oh), ω-hydroxylauric acid (C 12 ω-oh) and thrombin were obtained from Aldrich. Magnesium chloride (MgCl 2 ) was obtained from Kanto. PEG4000 was obtained from Katayama chemical. Imidazole was obtained from Kishida chemical. hydrogen peroxide labeled with 90% 18 O and water labeled with 99% 18 O were obtained from ICON. pbluescript II SK (+)-CYP152N1 was purchased from Biomatik. The sequence of synthetic gene (CYP152N1) was optimized for protein expression in E. coli ATGGGTAAAGTTATCCCGAAACAGGAAGGCCTGGATCACTCTGTGGACTTTCTGCG CGAGGGCTATCTGTTTGTGGCAAACCGCCGTAAAtctTTCCAGTCTAACATCTTCGAG AGCCGCCTGCTGGGCGAGCGTGTTATCTGCCTGGGTGGCGAAGAAGCTGCAGAGGT GTTTTATGACGCGAACAAATTCACCCGTCAGGACGCGGCACCGAAACGTCTGCTGA AAACCCTGTTCGGTGAAGGCGGTGTGCAGACCCTGGACGGTTCCGAACACACCCAC CGCAAGCAGATGTTCATGAGCCTGATGACCAAAGAAAACATTGATCGCCTGCTGCG CCTGACTTATCGTGAATGGAACCAGATCGAACGTATGGGTGAGGAAATCGTTCTGT ACGACATCGCACAGGAGGTGCTGATGAAAGCAGTGTGCGAATGGTCTGGTGTTCCG CTGGCTAAGGAAGAAGTGGGTAAGCGTACCGAAGAAATGCGTCTGCTGTTCGAATC TGGTACCTCTCTGGGTCCGACCTATCTGCAGGGTCGCAAAGCGCGTTCTTCTGCGGA AGTTTGGATTCGTCAGATGGTTAAAGAAGTTCGCTCTAACCGTCTGCTGCCGAACG AACATACTGCGCTGTATGAATTCTCTTGGCACCGTGATGAGAGCGGTGAACTGCTG CCGGAAGAGGTGGTGGCTGTTGAAGTGCTGAACATTCTGCGTCCGACTGTTGCTAT CTCTGTGTACGTGCTGTTTACCGTGCTGGCGCTGCACCAGTTTCCGGACGTTAAGGA ACAGGTTGAGCGTGGTGAGGTTTCTAAAACTGAGTTTGTGCAGGAAGTGCGCCGTT TCTACCCGTTTTTCCCGGTTGCAGCAGCTCGTGTTAAAACCGATTTCGAATGGGATG

GCTATGCGTTCCCGGAAGGTACCCTGACTCTGCTGGACCTGTACGGTACTAACCAC GACGTGTCTATTTGGACCGAACCGGATCGTTTCGACCCGTCTCGTTTCAAAGATTGG AAAGAATCTCCGTTCAACTTCATCCCGCAGGGCGGTGGTGATGTTGATTTTGGCCAC CGTTGCGCGGGTGAGCACGTTACCATCGCAATCCTGGCGCAGGTTATCGAACTGTT CACCAAGGAGTATGCGTATACCGTTCCGCCGCAGGATCTGTCTTACTCTTTCGTTGA CATGCCGTCCCTGCCGAAAAGCAAACTGCGTCTGACTCACCTGACCCGTAACCAGT AA Amino acid sequence of CYP152 family enzymes >CYP152A4 gi 154685541 ref YP_001420702.1 CypC [Bacillus amyloliquefaciens FZB42] 70% to CYP152A1 Bacillus subtilis MDEQIPHEKGLDNSLALLRDGYVFVKNRAENYRSDVFRARLLGKTFICMSGAEAAKLF YDTERFQREHALPKRVQKTLFGTGAIQAMDGERHKHRKLLFMSLMTPPRQKRLAEAV AKQWKASAEMWEGSNRIVLFDEAKKVLCRAACEWAGVPLKDSEVKERAEDFTDMVD AFGAVGPRHWKGRRARLKTEKWIEEVIEDVRSGKLQTPEGSALYEMAFHTELDGNRL DSHMAAVELINVLRPIAAISYFITFSALALHDYPEYRGKLRSRDDQEAERFAHEVRRYY PFAPFLGAVVKKDFVWKNCEFKKGASVMLDLYGTNHDSRLWENPNEFRPERFQGREE NKFDFIPQGGGDPANGHRCPGEGMTVEVMKTSLAFLANEIEYDVPSQDLSFSLSRMPAL PESGFVISDVRRI >CYP152A5 gi 226948314 ref YP_002803405.1 cytochrome P450 [Clostridium botulinum A2 str. Kyoto] 68% to CYP152A2 Clostridium acetobutylicum MLIEEHIPKDKGIDNTFALLQEGYLFIRNRVDRYQSNLFETHLFGQKVICMTGEEAAKLF YNEELFQRNGAAPKRIQKTLFGENAIQTMDDEEHIHRKHLFMSLMTPLSQKILAELVME KWKSSIDKWEHDKEIVLFNEAKETLCQISCKWAGVPLHKSEIKNRAEDFNLMVNALGA VGPQYWKGKMARSRAEKWISGIIQDVRSSRLDAEESTPLYAMAFHRDLDGNQMDTSM AAIELINVLRPIVAISTFITFAALGLYEHPECKEKLISGGDSYVEMFAQEVRRYYPFAPFL GARVRKDFILNECELKKGMLVLLDMYGTNHDSQIWEKPNEFYPERFKEWKGSLFDFIP QGGGDPVKTHRCPGEGITMEIMKGSLDFLVNKIEFQVPKQDLSYSLIKIPTLPKSGFIMT NIKRKF

>CYP152A6 gi 15614320 ref NP_242623.1 fatty acid alpha hydroxylase [Bacillus halodurans C-125] 57% to CYP152A1 Bacillus subtilis MKSNDPIPKDSPLDHTMNLMREGYEFLSHRMERFQTDLFETRVMGQKVLCIRGAEAV KLFYDPERFKRHRATPKRIQKSLFGENAIQTMDDKAHLHRKQLFLSMMKPEDEQELAR LTHETWRRVAEGWKKSRPIVLFDEAKRVLCQVACEWAEVPLKSTEIDRRAEDFHAMV DAFGAVGPRHWRGRKGRRRTERWIQSIIHQVRTGSLQAREGSPLYKVSYHRELNGKLL DERMAAIELINVLRPIVAIATFISFAAIALQEHPEWQERLKNGSNEEFHMFVQEVRRYYP FAPLIGAKVRKSFTWKGVRFKKGRLVFLDMYGTNHDPKLWDEPDAFRPERFQERKDS LYDFIPQGGGDPTKGHRCPGEGITVEVMKTTMDFLVNDIDYDVPDQDISYSLSRMPTRP ESGYIMANIERKYEHA >CYP152A7 gi 160881040 ref YP_001560008.1 cytochrome P450 [Clostridium phytofermentans ISDg] 68% to CYP152A3 YP_004308874.1 Clostridium lentocellum DSM 5427 MIVKKQIPRDKCIDNTFTLLKEGYLFIQNRTERYSSDVFETRLLGKKAICISGKEAPKLFY NPILMKKKGALPKRIQKTLFGVNAIQTMDGRRHLHRKKLFMTIMNQEEQDRLSKITTE KWQEAISRWEGASRVVLYDEVNRILCQSVCEWAGVPLPASEVKCRAKDFSTMVNTFT AIGPEYWKGKKARKRTEKWIRGIIEATRSGKLRPGRNSALHQIAYYKDLDGKLLSTQM AAVELINVLRPVVAISTFITFTAVALYEHREYIKILRSSDENMREMFVQEVRRYYPFTPFL GAITRKNFMWKGYNFKKGTLVILDVYGINHDARIWENPYKFRPERFSEKREHLFDFIPQ GGGDPSKGHRCPGEGITIELMKLSVDFLVNKLEFKIPEQELRYSLIKIPSLPKSGFIMRKIK TRTSM >CYP152B3 gi 110347019 ref YP_665837.1 fatty acid alpha hydroxylase, cytochrome P450 [Chelativorans sp. BNC1] 58% to CYP152B1 Sphingomonas paucimobilis 58% to CYP152B2 Azotobacter vinelandii 82% to gi 103488034 ref YP_617595.1 [Sphingopyxis alaskensis RB2256] MPRIPRDRSLDSTIALMGDPYRFISNRSRRYRSDLFETRLLLRKTICMTGPEAAQLFYDPS RFVRTGAMPKAIQKTLLGVGGVQGLDDDAHRHRKQMFMSLMTPERIEQLVQLTAAE WQIRVLKWGSMDEVVLYPELHLLLTRAVCAWAGVPLADSEVDARTKEIAALFDHAGA

VGLRHLWSRWARKQADRWIADIIDQIRSGRIRPPEQSAAHIIAWHRDLNGELLTPQIAA VELINVIRPTVAVSVYMLFVAHALHAHPKIRERLQADEDSYSRRFVQEVRRYYPFFPAV AARTRQAFDWNGYQFTAGRRVLLDLYGTNQDPRTWKRPEEFEPERFRHWDESPFNFIP QGGGDHYVNHRCPGEWIAIELMKLTADFLSRSMSYEVPQQDLRIDWSRLPALPRSRFVI RNVRES >CYP152B4 gi 103488034 ref YP_617595.1 fatty acid alpha hydroxylase, cytochrome P450 [Sphingopyxis alaskensis RB2256] 59% to CYP152B2 Azotobacter vinelandii 82% to gi 110347019 ref YP_665837.1 MSRIPRDKSLDSTIALMGDPYRFISNRCRRYRSDLFETRLLLRKTICMTGPEAARLFYDQ SRFARHGAMPKAIQKTLLGVGGVQGLDEGAHRHRKQMFMSLMTPEGIEKLVRLTSAE WQIRVRKWASMNAVVLYPELHALLTRAACAWAGVPLADSEVEPRTRQVTALFDHAG SIGLRHLWSRRARKRADSWAADIVEQIRSGRLRAPEHSAAHVVAWHRDFSGALLTPQV AAVELINVIRPTVAVSVYMIFVAHALHTHPQVREKLQAGDEDYAECFVQEVRRYYPFF PAVAAQTRLAFEWNGYQFPAGRRILLDLYGTNQDPRTWERPEDFEPERFGRRDGSPFN FIPQGGGDHYFDHRCPGEWIAIELMKLTADFLTRRMSYEVPGQDLRIEWSRLPALPRSR FVLSNVRECQELHLQRTRWRRR >CYP152B5 gi 256826347 ref YP_003150307.1 cytochrome P450 [Kytococcus sedentarius DSM 20547] 52% to CYP152B1 Sphingomonas paucimobilis MTPSNIKRADGTIALLRDPYRCISRRAAELGEDIFETRLLLRRTTCMTGAEAAAVFYDPS RFQRAGAAPPPLQKTLFGQGGVQGLDGENHRQRKAMFLQIVQPDRVEALAEAVTREW QRAVDDWIGQGRTRLYPELQLLLTRAVCAWAGVPLPAAEVNTRTRQLSALFDQAGHV GVGHLRSRAARKAADRWAADIIGQVRAGKLDPPASSAAYVIAHHRERDGRPMAPRVA GVELLNVLRPTVATAVYITFVAHALDAQPAWKERLALGDGHEDLAFVEEVRRHYPFFP AVAAIVREEFVWRGHRFPRGRRVLLDLYGTNHDSRIWPDPQRFDPDRFLGEEPDPFAFV PQGGGDPAVHHRCPGEPVSTRLMTVALDQMVRNMTYTALAPSAAVDFGRLPALPTDG YPIRLLARDTPA >CYP152N1 (P450 Exα )

gi 229918020 ref YP_002886666.1 cytochrome P450 [Exiguobacterium sp. AT1b] 48% to CYP152K1 Bacillus clausii KSM-K16 BAD65574 44% to CYP152H1 ZP_10970070.1 Sporolactobacillus vineae DSM 21990 MGKVIPKQEGLDHSVDFLREGYLFVANRRKSFQSNIFESRLLGERVICLGGEEAAEVFY DANKFTRQDAAPKRLLKTLFGEGGVQTLDGSEHTHRKQMFMSLMTKENIDRLLRLTY REWNQIERMGEEIVLYDIAQEVLMKAVCEWSGVPLAKEEVGKRTEEMRLLFESGTSLG PTYLQGRKARSSAEVWIRQMVKEVRSNRLLPNEHTALYEFSWHRDESGELLPEEVVAV EVLNILRPTVAISVYVLFTVLALHQFPDVKEQVERGEVSKTEFVQEVRRFYPFFPVAAA RVKTDFEWDGYAFPEGTLTLLDLYGTNHDVSIWTEPDRFDPSRFKDWKESPFNFIPQGG GDVDFGHRCAGEHVTIAILAQVIELFTKEYAYTVPPQDLSYSFVDMPSLPKSKLRLTHL TRNQ >CYP152P1 (CYP-MP) gi 188580553 ref YP_001923998.1 protein CypC [Methylobacterium populi BJ001] 60% to gi 170742430 ref YP_001771085.1 [Methylobacterium sp. 4-46] 45% to CYP152A1 Bacillus subtilis 45% to CYP152G1 ZP_16052477.1 Rhodopirellula baltica SH28 MPAAIATHRFRKARTLPREPAPDSTLALLREGYGFIRNRCRRHDSDLFAARLLLSPVICM SGAEAARHFYDGHRFTRRHALPPTSFALIQDHGSVMVLDGAAHLARKAMFLSLVGEE ALQRLAGLAERHWREAVSGWARKDTVVLLDEAHRVLTAAVCEWVGLPLGPTEVDAR AREFAAMIDGTGAVGPRNWRGHLYRARTERWVRKVIDEIRSGRRDVPPGAARTIAEHQ DADGQRLDRTVAGVELINVLRPTVANARYIVFAAMALHDHPHQRAALADGGEAAERF TDEVRRFYPFIPFIGGRVRAPFHFGGHDFREGEWVLMDLYGTNRDPRLWHEPERFDPD RFARETIDPFNMVSHGAGSARDGHRCPGEGITRILLRTLSRQLAATRYTVPPQDLTLDL AHVPARPRSGFVMRAVHAP >CYP152P2 gi 170742430 ref YP_001771085.1 cytochrome P450 [Methylobacterium sp. 4-46] 60% to CYP152P1 Methylobacterium populi 47% to CYP152H1 ZP_10970070.1 Sporolactobacillus vineae DSM 21990 MFAIPRDPAPDSTLALLREGYGFIPGRCRNFGSDLFTTRLMLTNVVCMTGADAAAQFY APDRFTRRGALPRISFTLIQDNGSVMVMDGEAHRRRKAMFLSLMSPEALQRLADLTTQ AWRARMRRWAAQETIPLFDEAHVPFCAAVCAWAGLPLNEAEAEERSREFLAMIEGTG

SIGPRNWRGHLLRARAERWMRDAIRQIREGSRAVPEGSAAHVIAHHRDAEGRLLDVRT SAVELINILRPTVANARYVVFAAHALHCYPESREALQAAEGVEPFVQEVRRFYPFIPFIG GRALQTVEFHGHRFAVGDWVLMDLYGTNRDPNRWGQPERFIPDRFAQWDHDPNGFIP QGGGAYETGHRCPGEWITIEQMRAVVPLLAREMRYVVPEQDLTIDLGRIPAMPKSRFVI TKVAG >CYP152Q1 gi 170783544 ref YP_001742037.1 putative fatty acid beta hydroxylase [Arthrobacter sp. AK-1] 44% to CYP152G1 ZP_16052477.1 Rhodopirellula baltica SH28 47% to CYP152C1 Rhodobacter sphaeroides MTVQLPDSSLALLREGYTFISSRCDRLGTDLFRTTLILRPVVCLRGAEAAEFFYGGGRFG RKAAMPRSAQHLLQDAGSVQSLQGSAHRRRKQLFLDLMTNESVERLGRAFDTEWHSA RERWQDSGEVVLHDEVRRVLTATACHWAGVSADRATVSRRARELSLMIDKAGAVGP VNWYARWRRRSTEKWAGECISSIRRNGPAAASGSPAAVIAFHTDEHGNPLSAEVAAVE LLNLLRPIVAVSRFMVFAAVALQQHPEWNDIVRKGQDADLDCFAQEVRRYYPFFPFVG GTARETLEWKGHTFKTGQWALFDLYGTNHDGRLWKDPESFNPARFRVWRPDPHTLVP QGAGDAAVGHRCPGEDITVDLIRRATRALAAESGISVPAQDLSIDLTRMPALPRSGFILS VGRASD >CYP152R1 gi 146283602 ref YP_001173755.1 fatty acid alpha hydroxylase [Pseudomonas stutzeri A1501] 47% to CYP152E1 gi 126657198 ZP_01728364 Cyanothece sp. CCY0110 46% to CYP152G1 ZP_16052477.1 Rhodopirellula baltica SH28 MTDIPRDDHLESSLALLGEGYPFIRDRCQRLHSNVFQARLLMQNTICLSGEQAARLFYD ERHFQRAQAMPRMLKKTLLGQGGVQGLDGEAHRHRKRMFLQLLDAAAVDELVGLTE RSWRQAIGQWQAQGEVQLLGELQMLLTDSVCRWAGVPLPSAERELRRDQLAQMIDG AGGIGPRHLAARKARREAEAWTQHLIEQVRAGELQGDPTRALMVVAHHRDLDGKPLD SRIAAVELLNLLRPTVAVAYFITYAALELLAHPHWCERLRAEDELLEPFAQEVRRLHAF FPFTAARVRDGFDWQGHHFPAGTRVMLDLWGTNREASRWTDPEAFQPERFVDWPGD AFGFVTQGGGDPAQGHRCPGERLAIELLKLALRMLTREMDYAVPAQDLRIDLSRMPAK PESGLLISDVRPRAS >CYP152S1 gi 91775795 ref YP_545551.1 fatty acid beta hydroxylase (cytochrome P450) [Methylobacillus flagellatus KT]

49% to CYP152H1 ZP_10970070.1 Sporolactobacillus vineae DSM 21990 49% to CYP152E1 gi 126657198 ZP_01728364 Cyanothece sp. CCY0110 MARPPLESTYALWKKGYVFIDSTCRALGVKAFRTRLMMRPAICMQGEAAARLFYDNE KFMRAGAMPARAKKTLVGEGGVQGMDGHAHRHRKQMFTRELMSPERIEHLVCLHRG HWKEAIQAWKPGSEIVLFREAQKLLCKSVCAWAGVPLTGHELDRRAREFGHMIDSGA KLGPHHWRGRWARKSCERWLGQLIEDIRHYGEQGQAGSILQSIAWHRDEHGQRLPLQ VAAVELINILRPTVAIAQLAVFCALALHSFPACRQKLQQGDEDYLGWFVLEVRRFYPFF PFLAAVVREDFRWQNLEFKRGQRVLLDIYGTHRDPALWQDPAQFIPERFKDWDGNSFG LIANGGATYEYHHRCPGEWITIALMKAITRMLVHEIEYTVPAQDLRLDLSRIPALPESGF IIQPVITPRYLEKKHANS

Supplemental Figures Fig. S1. A) The construction of transformation plasmid pqe30t-cyp152n1 and B) Agarose gel electrophoresis of pqe30t-cyp152n1 treated by BamHI and HindIII C) SDS-PAGE of purified CYP152N1 Fig. S2 Difference spectra between CYP152N1 (6.2 μm) without substrate and CYP152N1 with 50 μm of Myristic acid (Red), 10 μm Palmitic acid (Blue).

Fig. S3 Difference absorbance (ΔΔmAbs 390-422 ) plot between CYP152N1 without substrate and CYP152N1 with myristic acid (A) and palmitic acid (B). Fig. S4 HPLC chart equipped with Chiralpak AD-RH column and fluorescence detector for myristic acid hydroxylation catalyzed by CYP152N1 (Red). The retention time of α- hydroxymyristic acid (C14α-OH), β-hydroxymyristic acid (C14β-OH) and myristic acid (C14) were detected by 1:2:2 authentic samples (Black). The enantio-selectivity were determined by the product catalyzed by CYP152A1 and CYP152B18. Retention time: C14α-(R)-OH (33 min), C14α-(S)-OH (36 min), C14β-(R)-OH (50 min), C14β-(S)-OH (53 min), C14 (57 min).

Fig. S5 Michaelis-Menten plot (A) and Hanes-Woolf plot (B) of myristic acid hydroxylation catalyzed by CYP152N1 under the various concentration of myristic acid. Fig. S6 EI-Mass Fragment pattern at the peak of Fig.4A on 11.7 min (A, tridecanoic acid), 10.7 min (B, lauric acid), and 13.4 min (C, α-hydroxymyristic acid).

Fig. S7 Transition of fatty acid ratio under the myristic acid oxidation catalyzed by 1 μm CYP152N1 in the presence of 5 mm H 2 O 2 and 100 μm myristic acid. Fig. S8 GC-MS chart (MIC m/z = 117, 147) of α-hydroxy myristic acid oxidation in the presence of 200 μm (A) or 5 mm (B) H 2 O 2. Retention time of TMS derivatives: C 12 (10.0 min), C 13 (11.0 min), C 14 (12.0 min), C 13 α-oh (12.7 min), C 14 α-oh (13.7 min), C 14 β-oh (13.8 min) C 16 (13.9 min)

Fig. S9 Ratio of EI-Mass Fragment Intensity (m/z =270-280) at GC retention time of Tridecanoic acid trimethylsilyl ester (11.0 min) produced from (A) myristic acid and (B) α-hydroxy myristic acid using H 2 16 O 2 (black, Fig 2 or Fig S8) or H 2 18 O 2 (red). Fig. S10 Ratio of EI-Mass Fragment Intensity (m/z =280-290 or 270-280) of the reaction solution resulted at GC retention time of myristic acid (A, 12.0 min) or tridecanoic acid (B, 11.0 min) produced by myristic acid using H 2 16 O (black, Fig. 2) or

H 2 18 O (orange). Fig. S11 Pyridine hemochrome assay of CYP152N1. Black stick was shown as maximum absorption and minimum absorption of heme b. The maximum absorption of heme a and heme c was shown as red stick and blue stick. Stick length show as relative extinction coefficient (ε) in contrast with ε 557nm of heme b. Fig. S12 F o -F c omit map for the myristic acid was shown as green mesh contoured at 2.5σ level (A). 2F o -F c electron density maps of myristic acid and heme were shown as blue mesh at the 1.0σ level (B). Heme b, Arg239, and Cys359 were shown as white stick. Myristic acid was shown as orange stick. Iron cation and sixth ligand water were shown as sphere. The electron density of alkyl chain of fatty acid was unclear owing to the high flexibility.

Fig. S13 100 ns distributions of N-O distance between Arginene239 and Carboxylate. The plots of distance were shown as yellow or green color.

Fig. S14 100 ns distributions of O-H distance between oxygen atom of Compound I and hydrogen atom. The plots of hydrogen atom of myristic acid at (S)-α-hydrogen atom were shown as blue color. The plots of (R)-α-hydrogen atom were shown as red color.